Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
28.97
1.19 (4.28%)
BSENSE

Jan 19

BSE+NSE Vol: 59.68 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryKabra Drugs VS Pharmaceuticals & Biotechnology
 
1D
4.28%
-0.59%
1W
1.61%
-0.95%
1M
9.73%
-2.18%
YTD
-5.17%
-2.51%
1Y
187.97%
8.43%
3Y
573.72%
36.52%
5Y
567.51%
68.19%
10Y
59.18%
239.39%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
46.24%
0%
46.24%
6 Months
32.1%
0%
32.1%
1 Year
187.97%
0%
187.97%
2 Years
0%
0%
0.0%
3 Years
573.72%
0%
573.72%
4 Years
427.69%
0%
427.69%
5 Years
567.51%
0%
567.51%

Kabra Drugs for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available